...
首页> 外文期刊>Journal of AOAC International >Chromatographic Separation of the Novel Hypoglycemic Drug Mitiglinide in its Bulk Powder and Pharmaceutical Formulation: Forced Degradation and Validated Stability-Indicating HPTLC/Densitometry and HPLC/UV Methods
【24h】

Chromatographic Separation of the Novel Hypoglycemic Drug Mitiglinide in its Bulk Powder and Pharmaceutical Formulation: Forced Degradation and Validated Stability-Indicating HPTLC/Densitometry and HPLC/UV Methods

机译:新型低血糖药物分离的色谱分离在其散装粉和药物制剂中:强制降解和验证稳定性指示HPTLC /密度测定法和HPLC / UV方法

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Mitiglinide (MTG) is one of meglitinides group which are used for treatment of type two diabetes mellitus.
机译:背景:Mitiglinide(MTG)是用于治疗两种糖尿病的MeGlitinides组之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号